Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis Following Liraglutide Treatment, Investigating the Impact on Inflammation
Phase of Trial: Phase IV
Latest Information Update: 17 Nov 2016
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity; Osteoarthritis
- Focus Therapeutic Use
- Acronyms IM-LOSEIT-II
- 11 Nov 2016 Status changed from not yet recruiting to recruiting.
- 03 Nov 2016 Planned initiation date changed from 1 Oct 2016 to 1 Nov 2016.
- 13 Oct 2016 New trial record